These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8686956)

  • 1. The influence of angiographic endpoints on the outcome of lipid intervention studies. A proposal for standardization. REGRESS study group.
    Jukema JW; van Boven AJ; Zinderman AH; Bal ET; Reiber JH; Bruschke AV
    Angiology; 1996 Jul; 47(7):633-42. PubMed ID: 8686956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT).
    Kleemann A; Eckert S; von Eckardstein A; Lepper W; Schernikau U; Gleichmann U; Hanrath P; Fleck E; Neiss A; Kerber S; Assmann G; Breithardt G;
    Eur Heart J; 1999 Oct; 20(19):1393-406. PubMed ID: 10487800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS).
    de Groot E; Jukema JW; Montauban van Swijndregt AD; Zwinderman AH; Ackerstaff RG; van der Steen AF; Bom N; Lie KI; Bruschke AV
    J Am Coll Cardiol; 1998 Jun; 31(7):1561-7. PubMed ID: 9626835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group.
    Jukema JW; Zwinderman AH; van Boven AJ; Reiber JH; Van der Laarse A; Lie KI; Bruschke AV
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):425-30. PubMed ID: 8630669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).
    Jukema JW; Bruschke AV; van Boven AJ; Reiber JH; Bal ET; Zwinderman AH; Jansen H; Boerma GJ; van Rappard FM; Lie KI
    Circulation; 1995 May; 91(10):2528-40. PubMed ID: 7743614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS).
    Morice MC; Feldman TE; Mack MJ; Ståhle E; Holmes DR; Colombo A; Morel MA; van den Brand M; Serruys PW; Mohr F; Carrié D; Fournial G; James S; Leadley K; Dawkins KD; Kappetein AP
    EuroIntervention; 2011 Oct; 7(6):670-9. PubMed ID: 21959312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5-year angiographic follow-up of the Prevention of Coronary Sclerosis (PCS) study.
    Nakagawa T; Kobayashi T; Awata N; Sato S; Reiber JH; Nakajima H; Toyama YN; Hiraoka H; Kato O; Kirino M; Kobayashi T; Takeda Y; Yachiku K; Iida M; Itoh T; Shibata N
    Int J Cardiol; 2004 Oct; 97(1):107-14. PubMed ID: 15336816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the statistical modelling of coronary arteriographic data: dynamics of coronary atherosclerosis related to systemic and focal parameters. REGRESS Study Group. Regression Growth Evaluation Statin Study.
    Zwinderman AH; Jukema JW; van Boven AJ; Reiber JH
    Stat Med; 1997 Dec; 16(24):2829-41. PubMed ID: 9483717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
    Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin.
    Alipour A; Cabezas MC; Elte JW; Vallvé JC; Ribalta J; Zwinderman AH; Defesche JC; Jukema JW
    Atherosclerosis; 2011 Mar; 215(1):125-9. PubMed ID: 21211797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis.
    Jukema JW; van Boven AJ; Zwinderman AH; Van der Laarse A; Bruschke AV
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():111-8. PubMed ID: 9642484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting balloons for de novo coronary artery disease: a meta-analysis of angiographic and clinical data.
    Zhang T; Sun S; Shen L; He B
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1021-30. PubMed ID: 23703742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [REGRESS [The Regression Growth Evaluation Statin Study]].
    Hayashi K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():422-6. PubMed ID: 11347107
    [No Abstract]   [Full Text] [Related]  

  • 14. The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study.
    Jukema JW; van Boven AJ; Groenemeijer B; Zwinderman AH; Reiber JH; Bruschke AV; Henneman JA; Molhoek GP; Bruin T; Jansen H; Gagné E; Hayden MR; Kastelein JJ
    Circulation; 1996 Oct; 94(8):1913-8. PubMed ID: 8873668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of quantitative computerized and human panel coronary endpoint measures: implications for the design of angiographic trials.
    Mack WJ; Azen SP; Dunn M; Hodis HN
    Control Clin Trials; 1997 Apr; 18(2):168-79. PubMed ID: 9129860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis.
    de Maat MP; Jukema JW; Ye S; Zwinderman AH; Moghaddam PH; Beekman M; Kastelein JJ; van Boven AJ; Bruschke AV; Humphries SE; Kluft C; Henney AM
    Am J Cardiol; 1999 Mar; 83(6):852-6. PubMed ID: 10190398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
    Brener SJ; Ivanc TB; Hu T
    J Invasive Cardiol; 2008 Jun; 20(6):261-5. PubMed ID: 18523316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.
    Løland KH; Bleie O; Blix AJ; Strand E; Ueland PM; Refsum H; Ebbing M; Nordrehaug JE; Nygård O
    Am J Cardiol; 2010 Jun; 105(11):1577-84. PubMed ID: 20494665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
    Schwartz L; Kip KE; Alderman E; Lu J; Bates ER; Srinivas V; Bach RG; Mighton LD; Feit F; King S; Frye RL;
    Am J Cardiol; 2009 Mar; 103(5):632-8. PubMed ID: 19231325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angiographic analysis of coronary artery atherosclerosis.
    McLaughlin PR; Gladstone P
    Cathet Cardiovasc Diagn; 1998 Jul; 44(3):249-56. PubMed ID: 9676791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.